SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis
Clinical trial NCT06823375 · RECRUITING
Trial details
- NCT number
- NCT06823375
- Sponsor
- Chinese University of Hong Kong
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-10
- Primary completion
- 2027-07-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.